Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.
Vaishnaw outlined India’s AI-driven initiatives spanning healthcare, education, agriculture, weather forecasting, disaster ...
OpenAI chief executive Sam Altman, who provided the initial $180mn ... which will be tested in an early stage study in Australia this year. It is also working on drugs for rejuvenating blood ...
Sam Altman recently celebrated a significant ... His passion for technology emerged early in his life. According to his LinkedIn profile, Oliver attended the prestigious John Monash Science ...
As he continues to lead OpenAI, his influence on how AI integrates into daily life and impacts global economies remains profound. Altman's journey from a teenage startup founder to a pivotal figure in ...
Sam Altman's OpenAI launched ChatGPT Gov on Tuesday, which the company said government agencies could use to input sensitive information. Sam Altman hailed the Chinese firm's low-cost AI model as ...
Sam Altman has personally disputed an accusation now at the center of Elon Musk's federal racketeering lawsuit against him: Musk's claim that OpenAI investors must agree to a fund-no-competitor ...
The race to increase human life span through ... that’s set to enter an early-stage trial in Australia this year. Some of the investment will come from OpenAI CEO Sam Altman, who also provided ...
"That is false," Altman said Thursday in a sworn statement to a California judge. He said investors were only told they'd lose access to OpenAI data if they invested in a competitor. Sam Altman ...
"That is false," Altman said Thursday in a sworn statement to a California judge. He said investors were told only that they'd lose OpenAI data access if they invested in a rival. Sam Altman has ...
Sam Altman, pictured at President Donald Trump's inauguration, is contributing to another round of funding for Retro Biosciences.
"Trump represents an unprecedented threat to America," Altman wrote in 2016. The day after President Donald Trump returned to office, Sam Altman ... who -- in the early days of Trump's first ...